Internal Medicine, Cardiovascular Disease · Jersey City, NJ
NPI
1386726230
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
205 9th Street
Jersey City, NJ, 07302
Phone (201) 653-1144
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
603 services
Medicare patients, 2024
105
Average age 73
Drug cost, 2024
$3.7M
5,266 prescriptions
Company payments, 2025
$8,858
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joven P Dungo was code 99214 (office e&m - established), 230 times for 72 patients. In total Joven P Dungo billed 603 services in 31 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 230 | 72 | $105.15 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 103 | 20 | $100.05 | $10K |
| 99213 Office E&M - Established | Office | 53 | 33 | $66.29 | $3,513 |
| 93000 Electrocardiogram | Office | 45 | 34 | $12.02 | $541 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 24 | $13.46 | $363 |
| 99223 Hospital E&M - Initial | Facility | 21 | 17 | $146.05 | $3,067 |
| 93018 Electrocardiogram | Facility | 16 | 16 | $10.88 | $174 |
| 93016 Electrocardiogram | Facility | 16 | 16 | $16.49 | $264 |
| 78452 Myocardial Perfusion Scan | Facility | 16 | 16 | $59.21 | $947 |
By year: 2022 $71K for 2,416 services; 2023 $60K for 822 services; 2024 $49K for 603 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 106 | 51 | $2.95 | $313 |
| 85025 Blood Count | 64 | 44 | $7.64 | $489 |
| 84550 Clinical Chemistry | 63 | 42 | $4.45 | $280 |
| 83540 Clinical Chemistry | 58 | 42 | $6.37 | $369 |
| 83036 Blood Count | 57 | 42 | $9.56 | $545 |
| 84443 Clinical Chemistry | 57 | 42 | $16.53 | $942 |
| 84480 Clinical Chemistry | 57 | 43 | $13.95 | $795 |
| 80061 Clinical Chemistry | 56 | 42 | $13.18 | $738 |
| 84439 Clinical Chemistry | 55 | 42 | $8.87 | $488 |
| 84403 Clinical Chemistry | 54 | 41 | $25.40 | $1,371 |
Medicare prescription drug claims, 2024
In 2024, the drug Joven P Dungo prescribed most often to Medicare patients was Rosuvastatin Calcium, with 248 prescriptions and refills. In total Joven P Dungo wrote 5,266 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 248 | 670 | 72 | $4,536 |
| Losartan Potassium Generic | 245 | 660 | 66 | $2,006 |
| Jardiance Empagliflozin | 172 | 436 | 41 | $246K |
| Amlodipine Besylate Generic | 172 | 492 | 51 | $865 |
| Vascepa Icosapent Ethyl | 136 | 347 | 29 | $112K |
| Xarelto Rivaroxaban | 135 | 270 | 28 | $145K |
| Metformin Hcl Generic | 133 | 357 | 38 | $930 |
| Metoprolol Succinate Generic | 130 | 375 | 37 | $1,734 |
| Atorvastatin Calcium Generic | 122 | 352 | 42 | $1,301 |
| Pantoprazole Sodium Generic | 113 | 256 | 41 | $931 |
| Ozempic Semaglutide | 88 | 177 | 20 | $169K |
| Metoprolol Tartrate Generic | 88 | 205 | 29 | $502 |
| Levothyroxine Sodium Generic | 79 | 223 | 23 | $1,089 |
| Alprazolam Generic | 78 | 78 | 20 | $225 |
| Allopurinol Generic | 78 | 194 | 22 | $604 |
Brand drugs: 1,626 claims; generic drugs: 3,541 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joven P Dungo $8,858 ($8,858 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,719.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 42 | $1,719 |
| Abbott Laboratories ABT | 14 | $903 |
| Amgen Inc. AMGN | 41 | $695 |
| Intra-Sana Laboratories | 12 | $689 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $618 |
| Edwards Lifesciences Corporation EW | 4 | $462 |
| ANI Pharmaceuticals, Inc. ANIP | 22 | $410 |
| Novo Nordisk Inc NVO | 14 | $389 |
| Corcept Therapeutics CORT | 27 | $374 |
| GlaxoSmithKline, LLC. GSK | 4 | $271 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.